NextPlat shares fell 15.3% after the earnings release, with the transcript pointing to ongoing pressure in retail pharmacy revenue and a sequential $0.3 million decline in medication-fulfillment contracts after a customer closed a facility. Management also delayed the healthcare e-commerce launch to this month, tempering the turnaround narrative despite year-over-year improvement in margins and operating losses.
NextPlat Corp's Q3 2025 earnings reflect ongoing operational challenges, but improvements in revenue and cost management signal a positive trajectory moving into 2026.